Samad Nazar Poor

Systemic thrombolysis may still be considered as a potentially effective and safe treatment option for massive pulmonary embolism in thrombocytopenic patients with antiphospholipid syndrome, even in the presence of relative contraindications. This antiphospholipid syndrome case highlights the potential safety and effectiveness of systemic thrombolysis, suggesting more research to assess such high-risk situations and provide reliable protocols.